You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華潤三九(000999.SZ)2019年度淨利升47.51%至21.12億元 擬10派4.3元
格隆匯 03-19 21:18

格隆匯3月19日丨華潤三九(000999.SZ)發佈2019年年度報告,實現營業收入147.02億元,同比增長9.49%;歸屬於上市公司股東的淨利潤21.12億元,同比增長47.51%;歸屬於上市公司股東的扣除非經常性損益的淨利潤12.03億元,同比減少4.11%;基本每股收益2.16元;擬每10股派送現金4.30元(含税)。

2019年,歸屬於上市公司股東的淨利潤同比增長47.51%,主要是因公司通過公開掛牌轉讓,於2019年1月完成出售所持深圳市三九醫院有限公司82.89%股權,給公司帶來約6.8億元(税後)資產處置收益,上述收益為非經常性損益。

2019年營業收入增長9.49%,超越行業增長速度,符合預期。其中,自我診療(CHC)業務實現營業收入75.56億元,同比增長13.36%;處方藥業務實現營業收入65.90億元,同比增長6.36%。實現經營活動產生的現金流量淨額19.72億元,同比增長3.17%。

實現歸屬於上市公司股東的淨利潤21.12億元,同比增長47.51%,其中包括出售子公司三九醫院股權取得的投資收益約6.8億元(税後)以及2019年四季度公司計提的商譽減值準備1.92億元。剔除上述兩項影響因素,公司淨利潤同比增長約13%。本期商譽減值準備主要為對眾益製藥形成的商譽計提1.72億元,對吉林和善堂形成的商譽計提1957.40萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account